Gale, R. P. http://orcid.org/0000-0002-9156-1676
Phillips, G. L.
Lazarus, H. M. http://orcid.org/0000-0002-1159-5607
Article History
Received: 2 February 2024
Revised: 27 February 2024
Accepted: 28 February 2024
First Online: 8 March 2024
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd. HL is a paid consultant to Partner Therapeutics and GllycoMimetics and has stock options; a paid consultant to Actinium Pharmaceuticals, Inc., CSL Behring, Jazz Pharmaceuticals, Inc., Pluri-Biotech, Inc., Seattle Genetics; on the speaker bureau for Jazz Pharmaceuticals; a promotional speaker for Seattle Genetics and AstraZeneca; and on a data safety monitoring board for Bristol-Myers Squibb and Biosight. RPG is an Editor of <i>LEUKEMIA</i>.